Bonescreen
Bonescreen is a Munich-based medical AI company that provides CE-certified deep-learning software for opportunistic osteoporosis screening and automated spine analysis from routine CT scans, serving radiology practices, hospitals, and research institutions in the DACH region.
- Company typePrivate
- Founded2022
- HeadquartersMünchen, Germany
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Bonescreen does
Bonescreen GmbH is a Munich-based medical AI company founded in 2022 that develops deep-learning software for extracting bone health biomarkers from routine spine CT scans. Its flagship product, SpineQ, is a CE-certified medical device under the EU MDR that performs opportunistic osteoporosis screening by generating calibrated bone mineral density (BMD) measurements, vertebral fracture detection, and full-spine anatomical annotation from CT data already acquired for other clinical reasons, with no additional radiation exposure to the patient. Its secondary product, SpineR, is a research-use automated spine segmentation and labeling tool used by academic and industry partners for surgery planning, PACS overlays, finite element modeling, and 3D printing. The technology was incubated over seven years through two European Research Council grants at the Technical University of Munich and is supported by peer-reviewed clinical evidence reporting 81% specificity for vertebral fracture prediction versus conventional DXA.
Bonescreen sells SpineQ via enterprise subscription licenses to radiology practices, hospitals, and university medical centers, primarily in Germany and Switzerland, using a direct, demo-led sales motion with dedicated Customer Success Managers handling pilot installation, contract negotiation, go-live, and long-term adoption. SpineR is licensed to academic research institutions and medical device companies on a subscription basis, and the company also derives some non-dilutive grant income (notably the up to €1.5M EIT Health Wildcard award and Bavarian State Ministry project funding). Customers and research partners include TUM University Hospital, University Hospital Ulm, Wake Forest University, Balgrist, Inselspital, LMU Klinikum, and LEM Surgical (for spine surgical robotics integration). The company is privately held, headquartered at Orleansstraße 34 in Munich, part of the TUM Venture Lab Healthcare incubator, and operates with a small interdisciplinary team combining radiology, computer science, and regulatory expertise.
Bonescreen firmographics
Firmographics- Name
- Bonescreen
- Legal name
- Bonescreen GmbH
- Website
- https://bonescreen.de
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Bonescreen is a Munich-based medical AI company that provides CE-certified deep-learning software for opportunistic osteoporosis screening and automated spine analysis from routine CT scans, serving radiology practices, hospitals, and research institutions in the DACH region.
- Ownership category
- akta.pro rank
Where Bonescreen is headquartered
LocationHeadquarters
- HQ city
- München
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Bonescreen business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Others
Revenue model
- SpineQ Medical Device License: CE-certified medical device (SpineQ) sold to radiology practices and hospitals for clinical use in osteoporosis screening. Revenue derived from software licensing with clinical deployment.
- SpineR Research Software: Research-purpose software (SpineR) licensed to research institutions, universities, and medical device companies for spine analysis applications including surgery planning and 3D modeling.
- Professional Services: Implementation, onboarding, and customer success services to support clinical adoption of SpineQ in radiology workflows.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise clinical licensing for radiology practices and hospitals |
| Subscription | Annual | Research licensing for academic and research institutions |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Bonescreen product offering
Product offeringCore offering
Bonescreen develops AI-based medical imaging software that analyzes routine spine CT scans to extract bone health biomarkers. Its flagship product SpineQ is a CE-certified medical device that opportunistically screens for osteoporosis and detects vertebral fractures from existing CT data without additional radiation. The companion research product SpineR provides automated spine segmentation and vertebral labeling for surgical planning, PACS integration, finite element modeling, and 3D printing applications.
Product overview
Bonescreen offers two AI-powered products for spine health assessment. SpineQ® is a CE-certified medical device for clinical osteoporosis diagnosis that analyzes existing CT scans to provide bone mineral density measurements and fracture detection. SpineR is a research-focused automated spine processing tool that segments vertebrae and identifies anatomical landmarks for applications including surgery planning, PACS-overlays, finite element modelling, and 3D printing. Both products leverage AI-based analysis of CT images but serve different market segments—SpineQ for clinical use and SpineR for research applications.
Differentiator
Problem solved
Functional benefit
Brands
- SpineQ®: CE-certified medical device AI software that assists clinicians in diagnosing osteoporosis from routine CT scans of the spine. Provides comprehensive spine reports with calibrated bone mineral density measurements and osteoporotic fracture identification.
- SpineR
Products and services
- SpineQ SpineQ is a CE-certified AI-powered medical device that assists clinicians in diagnosing osteoporosis from existing routine CT scans of the spine. It produces comprehensive spine reports including complete annotation, calibrated and reproducible bone mineral density (BMD) measurements, and identification of osteoporotic fractures, enabling opportunistic screening without additional radiation exposure for patients. It is intended for radiology practices, hospitals, and clinicians.
- SpineR SpineR is an automated spine processing solution for CT scans that segments and labels all vertebrae and identifies subregions including anatomical landmarks. It is designed for research and applications such as automated surgery planning, PACS overlays, finite element modeling, and 3D printing, offering higher precision than conventional spine segmentation methods with high computational efficiency and no GPU requirement. It is not developed as a medical device and is targeted at research institutions, universities, and medical device companies.
Quantifiable outcome
- 81% specificity for predicting vertebral fractures vs. conventional DXA
- +3 more outcomes
Companies that use Bonescreen
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles3 records
Bonescreen technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature4 records
Bonescreen partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- LEM SurgicalcorePartnership to advance next-generation spine surgical robots. Bonescreen contributes machine learning expertise to support LEM's robotics technology. Both partners committed to integrating robotics, automation, and spine imaging advancements to improve patient care.
- TUM Venture Lab HealthcareminorBonescreen admitted to TUM Venture Lab Healthcare incubator - a joint initiative by Technical University of Munich and UnternehmerTUM supporting MedTech and digital healthcare startups with workspaces, laboratory equipment, and venturing programs.
- University Hospital Ulm - Radiology DepartmentcoreMulti-year cooperation to improve patient care in bone health and contribute to research and technology development. Both institutions aim to advance the field of bone health diagnostics and treatment.
- TUM University Hospital (Neurosurgery and Neuroradiology)coreJoint project funded by Bavarian State Ministry (via Bayern Innovativ) focused on spine imaging and analysis technology development.
- Dr. Weaver's Lab at Wake Forest UniversitycoreResearch partnership enabling automated spine segmentation for bone strength and spinal fracture risk studies. Dr. Weaver's lab uses Bonescreen to obtain hundreds of segmentations that were previously manual and time-consuming.
- Balgrist University Hospital (Switzerland)minorResearch and scientific partnership in spine imaging and bone health. Balgrist is a leading orthopedic university hospital.
- LMU Klinikum (Munich)minorAcademic medical partnership for research and clinical collaboration in bone health imaging.
- University of CalgaryminorInternational academic research partnership in spine and bone health imaging.
- Inselspital (Bern, Switzerland)minorSwiss university hospital partnership for spine research and bone health technology.
- University of BernminorAcademic partnership for bone health research and imaging technology development.
- Uppsala University (UKU)minorSwedish academic partnership for spine imaging research.
- TUM MIBE (Munich Institute of Biomedical Engineering)coreDeep research collaboration with TUM's biomedical engineering institute. Bonescreen participated in Bioengineering Day panel discussion on AI in medical applications.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Bonescreen competitors and assessment
Company assessmentDirect peers
- Koios Medical: AI-powered medical imaging company focused on ultrasound and CT decision support, with FDA-cleared products for breast and thyroid lesion classification. Comparable as a focused, CE/FDA-cleared clinical imaging AI vendor selling into radiology workflows.
- Aidoc: Provider of AI-powered medical imaging analysis for radiologists, offering a broad suite of clinical AI modules integrated into radiology workflows. Highly comparable as a radiology AI platform serving hospital and imaging-center customers with subscription-based clinical decision support.
- Qure.ai: AI company focused on interpreting medical images (chest X-ray, head CT, chest CT) using deep learning, with regulatory clearances across multiple geographies. Comparable as a radiology AI specialist selling CE/FDA-cleared clinical decision support software to hospitals.
- Annalise.ai: AI medical imaging company that provides comprehensive clinical decision support across a wide range of findings on chest X-rays and CT scans. Comparable as a deep-learning radiology AI vendor selling into enterprise hospital networks globally.
- Lunit: Medical AI company developing imaging biomarkers for cancer screening and treatment, with CE-marked and FDA-cleared products integrated into PACS and mammography workflows. Comparable as a clinically validated, regulatory-cleared specialty imaging AI vendor with a similar commercial model.
- Paige.AI: AI company applying deep learning to pathology and radiology images, with FDA-authorized clinical AI products. Comparable as a regulated clinical AI vendor that has translated academic research into commercially deployed medical device software.
Emerging players
- HeartFlow: Medical technology company using AI applied to CT imaging to assess coronary artery disease non-invasively. Comparable as a specialty AI medical device company that extracts quantitative clinical insights from routine CT scans for hospital-based clinicians.
- Perspectum: Medical imaging company providing AI-based quantitative analysis of MRI scans for liver, prostate, and other organ-specific disease assessment. Comparable as an opportunistic, biomarker-extraction AI imaging vendor with a specialty clinical focus and hospital research partnerships.
Broad incumbents
- DeepHealth (RadNet subsidiary): AI radiology platform acquired by RadNet, providing a portfolio of FDA-cleared AI tools for breast, prostate, and lung imaging embedded across one of the largest outpatient imaging networks in the US. Comparable as a vertically integrated radiology AI vendor, though operating at much larger scale.
- Zebra Medical Vision (Nanox): Acquired by Nanox and now part of a broader imaging hardware-plus-AI platform offering AI analytics across multiple imaging modalities. Comparable as a multi-condition radiology AI vendor but operating as part of a larger imaging-device ecosystem rather than a niche specialist.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Bonescreen social profiles
Digital presenceBonescreen compliance and trust
Trust signalCompliance4 records
Bonescreen financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bonescreen leadership team
Management profileNumber of profiles
Profiles8 records
Bonescreen funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bonescreen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bonescreen
What does Bonescreen do?
Bonescreen develops AI-based medical imaging software that analyzes routine spine CT scans to extract bone health biomarkers. Its flagship product SpineQ is a CE-certified medical device that opportunistically screens for osteoporosis and detects vertebral fractures from existing CT data without additional radiation. The companion research product SpineR provides automated spine segmentation and vertebral labeling for surgical planning, PACS integration, finite element modeling, and 3D printing applications.
Is Bonescreen a public or private company?
Bonescreen is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Bonescreen founded?
Bonescreen was founded in 2022. It employs 1 to 10 people.
Where is Bonescreen based?
Bonescreen is headquartered in München, Germany, in the Europe region.
How does Bonescreen make money?
Three revenue lines are on record. SpineQ Medical Device License is the primary driver. The others are spineR Research Software and professional Services.
Who are Bonescreen's main competitors?
Direct peers on record are Koios Medical, Aidoc, Qure.ai, Annalise.ai, Lunit and Paige.AI. Emerging players are HeartFlow and Perspectum. Broad incumbents are DeepHealth (RadNet subsidiary) and Zebra Medical Vision (Nanox).
Does Bonescreen have an API?
No public API is recorded for Bonescreen.